Anti-diabetic drugs could lower risk of primary and secondary brain cancer
by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with
Updated on: April 07,2024
16

Anti-diabetic drugs could lower risk of primary and secondary brain cancer
by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with
Updated on:April 07,2024
16
